Stay updated on FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.

Latest updates to the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page
- Check5 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoChange DetectedNo substantive content changes detected; the page structure appears to have been updated without changing the core study details.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.4.2 has been added, and the notices related to government funding and the previous revision (v3.4.1) have been removed.SummaryDifference0.5%

- Check40 days agoChange DetectedA site-wide notice about funding-related information accuracy and the NIH Clinical Center status was added, and the page revision updated to v3.4.1.SummaryDifference0.5%

- Check47 days agoChange DetectedAdded a 'Show glossary' option and updated metadata to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision label v3.4.0; the previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and v3.3.4 were removed.SummaryDifference0.2%

- Check54 days agoChange DetectedKyntra Bio is now listed as sponsor and responsible party for the study, replacing FibroGen.SummaryDifference0.3%

Stay in the know with updates to FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.